Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 9, 2010

Sigma Life Science and SwitchGear Genomics to Develop miRNA Target-Validation System

  • Sigma Life Science and SwitchGear Genomics signed a deal to develop and distribute an miRNA target reporter system.

    Use of Sigma's patented lentiviral technology is expected to allow the SwitchGear GoClone™ miRNA target sets to be used in a range of cell types including primary cells and stem cells.

    “We believe that combining unique technologies from SwitchGear Genomics with Sigma's industry-leading lentiviral technology and production capabilities will enable researchers to study miRNA function and gene regulation on an unprecedented scale,” says Nathan Trinklein, Ph.D., CEO and co-founder of SwitchGear Genomics.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »